RU2007135967A - REGENERATING ANTI-INFLAMMATORY PRODUCT AND METHODS OF TREATMENT USING THIS PRODUCT - Google Patents
REGENERATING ANTI-INFLAMMATORY PRODUCT AND METHODS OF TREATMENT USING THIS PRODUCT Download PDFInfo
- Publication number
- RU2007135967A RU2007135967A RU2007135967/15A RU2007135967A RU2007135967A RU 2007135967 A RU2007135967 A RU 2007135967A RU 2007135967/15 A RU2007135967/15 A RU 2007135967/15A RU 2007135967 A RU2007135967 A RU 2007135967A RU 2007135967 A RU2007135967 A RU 2007135967A
- Authority
- RU
- Russia
- Prior art keywords
- regenerating
- treatment
- acid
- comenic acid
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
1. Регенерирующее противовоспалительное средство, представляющее собой водный раствор активного начала - коменовой кислоты и вспомогательного вещества - натрия гидрокарбоната, при следующем соотношении компонентов, мас.%: ! Коменовая кислота 1-2, преимущественно 1 и 2Натрия гидрокарбонат 0,55-1,1Вода для инъекций до 100 ! 2. Регенерирующее противовоспалительное средство по п.1, отличающееся тем, что оно дополнительно содержит примесь коменовой кислоты - бензилкоменовую кислоту - в количестве не более 2,5% в пересчете на коменовую кислоту. ! 3. Способ лечения хориоретинальных дистрофий различной этиологии, заключающийся в том, что пациенту вводят регенерирующее средство по пп.1-2 парабульбарно в дозе от 10 до 20 мг (в пересчете на коменовую кислоту) один раз в сутки в течение 10 дней. ! 4. Способ лечения по п.3, отличающийся тем, что курс лечения повторяют 2-3 раза в год. ! 5. Способ лечения по п.3, отличающийся тем, что пациенту вводят регенерирующее средство в один или оба глаза. ! 6. Способ повышения эффективности противотуберкулезной терапии, заключающийся в том, что пациенту вводят регенерирующее средство по пп.1-2 внутривенно в дозе до 350 мг в сутки (в пересчете на коменовую кислоту) в течение 10 дней. ! 7. Способ лечения по п.6, отличающийся тем, что курс лечения проводят 1-3 раза в год с перерывом в 3-6 мес.1. A regenerating anti-inflammatory agent, which is an aqueous solution of the active principle - comenic acid and auxiliary substance - sodium bicarbonate, in the following ratio, wt.%:! Comenic acid 1-2, mainly 1 and 2 Sodium bicarbonate 0.55-1.1 Water for injection up to 100! 2. The regenerating anti-inflammatory agent according to claim 1, characterized in that it additionally contains an admixture of comenic acid - benzylcomenic acid - in an amount of not more than 2.5% in terms of comenic acid. ! 3. A method for the treatment of chorioretinal dystrophies of various etiologies, which consists in administering to the patient a regenerating agent according to claims 1 to 2 parabulbar at a dose of 10 to 20 mg (in terms of comenic acid) once a day for 10 days. ! 4. The treatment method according to claim 3, characterized in that the course of treatment is repeated 2-3 times a year. ! 5. The treatment method according to claim 3, characterized in that the patient is administered a regenerating agent in one or both eyes. ! 6. A way to increase the effectiveness of anti-tuberculosis therapy, which consists in the fact that the patient is administered a regenerating agent according to claims 1 to 2 intravenously at a dose of up to 350 mg per day (in terms of comenic acid) for 10 days. ! 7. The treatment method according to claim 6, characterized in that the course of treatment is carried out 1-3 times a year with a break of 3-6 months.
Claims (7)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007135967/15A RU2362554C2 (en) | 2007-09-27 | 2007-09-27 | Regenerating resolvent and ways of treatment by means of this agent |
PCT/US2008/077555 WO2009042708A1 (en) | 2007-09-27 | 2008-09-24 | Regeneration anti-inflammatory composition and method for treating a retinal dystrophy using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007135967/15A RU2362554C2 (en) | 2007-09-27 | 2007-09-27 | Regenerating resolvent and ways of treatment by means of this agent |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2007135967A true RU2007135967A (en) | 2009-04-10 |
RU2362554C2 RU2362554C2 (en) | 2009-07-27 |
Family
ID=40511837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007135967/15A RU2362554C2 (en) | 2007-09-27 | 2007-09-27 | Regenerating resolvent and ways of treatment by means of this agent |
Country Status (2)
Country | Link |
---|---|
RU (1) | RU2362554C2 (en) |
WO (1) | WO2009042708A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2528914C1 (en) * | 2013-09-12 | 2014-09-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") | Neuroprotective pharmaceutical agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH658595A5 (en) * | 1983-08-17 | 1986-11-28 | Inst Khim Fiz An Sssr | RETINO PROTECTOR FOR THE TREATMENT OF EYE DISEASES. |
US5411985A (en) * | 1993-05-17 | 1995-05-02 | Merck & Co., Inc. | Gamma-pyrone-3-acetic acid as an inhibitor or interleukin-1 β inventory enzyme |
US20050054586A1 (en) * | 2003-06-30 | 2005-03-10 | Bartels Stephen P. | Treatment of ophthalmic disorders |
US8093408B2 (en) * | 2005-06-21 | 2012-01-10 | The Company Wockhardt | Antidepressant oral pharmaceutical compositions |
-
2007
- 2007-09-27 RU RU2007135967/15A patent/RU2362554C2/en not_active IP Right Cessation
-
2008
- 2008-09-24 WO PCT/US2008/077555 patent/WO2009042708A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009042708A1 (en) | 2009-04-02 |
RU2362554C2 (en) | 2009-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023000798A (en) | Functionalized peptides as antiviral agents. | |
CR20210563A (en) | Compounds and methods for the treatment of covid-19 | |
RU2013108857A (en) | COMPOUNDS FOR TREATMENT / PREVENTION OF INFLAMMATORY EYE DISEASES | |
RU2011153403A (en) | STABILIZED COMPOSITION CONTAINING AT LEAST ONE ADRENERGIC COMPOUND | |
RU2013121788A (en) | HIV REPLICATION INHIBITORS | |
MX2022011804A (en) | Use of agents for treatment of respiratory conditions. | |
AR039164A1 (en) | VENLAFAXINE SALTS OF LOW WATER SOLUBILITY | |
TW200639159A (en) | Treatment of pain | |
CA3019769C (en) | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | |
MX2023001756A (en) | Functionalized peptides as antiviral agents. | |
RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
ES2570401T3 (en) | Methods of treatment using single doses of oritavancin | |
RU2006128504A (en) | SYNTHETIC ANALGETIC PRODUCT AND METHOD OF TREATMENT BASED ON THIS PRODUCT | |
Douglas et al. | The respiratory stimulant action of 5-hydroxytryptamine (serotonin) in the dog | |
CA2377024A1 (en) | Ophthalmic composition comprising ketotifen | |
MX2007009312A (en) | Injectable preparations of diclofenic and its pharmaceutically acceptable salts. | |
AR045263A1 (en) | METHOD, KIT AND PHARMACEUTICAL COMPOSITION TO TREAT VIRAL INFECTIONS | |
MX2023003332A (en) | Line-1 inhibitors to treat disease. | |
MX2022012923A (en) | Inhibitors of trpc6 for treating respiratory conditions. | |
RU2007135967A (en) | REGENERATING ANTI-INFLAMMATORY PRODUCT AND METHODS OF TREATMENT USING THIS PRODUCT | |
RU2010129409A (en) | METHOD FOR TREATING RABBIT PSOROPTOSIS AND CARNIVOR ANIMAL OTODEKTOSIS | |
DE60128472T2 (en) | COMBINED TUMOR THERAPY BASED ON DISTAMYCIN ACRYLOYL DERIVATIVES AND ALKYLATIVES | |
KR20190117318A (en) | Injection composition containing deoxycholic acid having excellent stability and method for preparing the same | |
RU2003113210A (en) | TREATMENT OF CANCER DISEASES | |
KR20210039413A (en) | Combination therapy for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140928 |